Navigation Links
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Date:7/8/2008

- Focalin XR demonstrated better symptom control versus Concerta from 30

minutes to six hours post-dose in primary and secondary endpoints - Only Focalin XR provided onset of effect as early as 30 minutes post-dose - Additional analysis suggests Focalin XR provides comparable efficacy to

Concerta over 12 hours

- Symptoms of Attention Deficit/Hyperactivity Disorder (ADHD) can significantly impact a child's ability to focus and learn in an educational

setting

EAST HANOVER, N.J., July 8 /PRNewswire/ -- A head-to-head study, published in the June Journal of Child and Adolescent Psychopharmacology, confirms that Focalin(R) XR (dexmethylphenidate HCl) extended-release capsules offer greater improvements in managing symptoms of Attention Deficit/Hyperactivity Disorder compared with Concerta(R) (d,l- methylphenidate HCl) extended-release tablets at two hours post-dose, the primary study endpoint.

Focalin XR 20 mg and 30 mg2 also demonstrated better symptom control versus Concerta 36 mg and 54 mg respectively, from 30 minutes to 6 hours. Symptom control was demonstrated as early as 30 minutes post-dose with Focalin XR 20 mg and 30 mg versus placebo. Neither dose of Concerta was effective versus placebo at 30 minutes. Novartis is seeking revised labeling to reflect the 30-minute onset of action.

"There are many things to consider when determining which treatment is best for a patient, including lifestyle implications," said Alice Mao, M.D., Associate Professor of Psychiatry at the Baylor College of Medicine. "The results of this study demonstrate the benefits of Focalin XR during the early part of the day, which may be better for children who need their medication to begin working before they leave for school and continue working throughout the day."

Attention Deficit/Hyperactivity Disorder affects approximately three to seven percent of children in the United Stat
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
2. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
3. New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...Nov. 27 At the upcoming Radiologic...starting Sunday, Royal Philips Electronics ( PHG, ...re imaging and informatics solutions designed to d...e providers, by delivering meaningful imaging inno...rice points and easy upgradability. This focus wi...
(Date:11/25/2009)...ass., Nov. 25 Hologic, I...eading developer, manufacturer and supplier of pre...ical products dedicated to serving the healthcare ... Radiological Society of North America (RSNA) at M...ember 3, 2009 to highlight our new SecurView(®...
(Date:11/25/2009)....J., Nov. 25 The FDA granted tradi...ablets, a non-nucleoside reverse transcriptase inh...ically indicated for use in treatment-experienced ... HIV-1 strains resistant to an NNRTI and other ant...l is based on 48-week data from two Phase 3 studie...
Breaking Medicine Technology:Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Orexigen 28R 29 Therapeutics Appoints Mark Booth Chief Commercial Officer 13661 1Orexigen 28R 29 Therapeutics Appoints Mark Booth Chief Commercial Officer 13661 2Aflac Launches Soccer Its Eighth New Television Ad for 2009 55112 1Aflac Launches Soccer Its Eighth New Television Ad for 2009 55112 2Aflac Launches Soccer Its Eighth New Television Ad for 2009 55112 3Prostate Cancer Kills Every 20 Minutes 3B September Is Prostate Cancer Awareness Month 55111 1Prostate Cancer Kills Every 20 Minutes 3B September Is Prostate Cancer Awareness Month 55111 2
(Date:11/29/2009)... Traditional healthcare,s uncerta...e affordable alternative care. Affordable Acupunct... (PRWEB) November 29, 2009 -- Affordable ...his year (2009) and has been met with enthusiasm a...success can be attributed to two things, need and ...
(Date:11/28/2009)...offer tips to help lift spirits, recognize signs o...thDay News) -- For many seniors, the holiday seaso...loved ones, struggle with health issues or worry a...iatrics Society. , To help overcome the seasona...fers the following advice: , Get out and sociali...
(Date:11/27/2009)..., SAN FRANCISCO, Nov. 27 /PRNewswire-FirstCall/ -...ced that Blair Lambert, CFO/COO, will present at t... held at the May Fair Hotel in London, England, on..., To listen to a live broadcast of The Gymboree...ase log on to www.gymboree.com, click on "Our Comp...
(Date:11/27/2009)...and cycling plus low-emission vehicles may reduce ..., FRIDAY, Nov. 27 (HealthDay News) -- Encouraging...g cars would offer much greater public health bene... U.K. researchers have found. , The study compa...ative urban land transport scenarios for London, E...
(Date:11/27/2009)... Specialist manufacturers who use... are saving millions of dollars by bringing in tec...s. Increasing numbers of pro-active medical manufa...t the concept stage of their projects, ensuring th...sign processes or potentially outdated technology....
Breaking Medicine News(10 mins):Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...Hint of Sweetness Through Simple Ingredients , , ...mier natural food company, today announced the lau...ries pure ingredients with real vanilla to create ... delicate, unique flavor that Island Vanilla bri...
...h 31 /PRNewswire-Asia/ -- WuXi AppTec announced to... been inspected by the U.S. Food and,Drug Administ...hich is used to,report any non compliance issues a...shed in 2005. BAS provides,Good Laboratory Practic...
... Milliman,s fourth annual Guaranteed Living Benefi...VA) carriers revealed that about 96% of variable a...les of VAs that offered a GLB during calendar year...008 with 96% of total VA sales offering a GLB. , ...
... Certification Confirms MedL10N Division,s C...ijing, China (PRWEB) March 31, 2009 -- CSOFT Inter...localization, testing and outsourced software deve...n. This ISO certification specifies the necessary...
...h 31 /PRNewswire-Asia/ -- Tiens Biotech Group (USA...S: TBV), http://www.tiens-bio.com ,today announc...ended,December 31, 2008. , For the twelve mont... Net income for the twelve months ended Decembe...
...igh-grade refractory patients recruited in trial;,...e in one year-, , , BELLEVILLE, ON, March 31 /PRN...TSX: BNC), a research-based, technology-driven Can... in the treatment of non-muscle-invasive bladder c...
Other Medicine News:Health News:Kashi Company Expands With New Island Vanilla(TM) Biscuit Cereal 2Health News:WuXi AppTec Bioanalytical Services Unit Passes FDA Inspection 2Health News:Milliman Survey Says Variable Annuity Guarantees Dominate Annuity Products 2Health News:Milliman Survey Says Variable Annuity Guarantees Dominate Annuity Products 3Health News:CSOFT Earns ISO 13485:2003 Certification for Medical Device Industry 2Health News:CSOFT Earns ISO 13485:2003 Certification for Medical Device Industry 3Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 2Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 3Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 4Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 5Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 6Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 7Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 8Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 9Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 10Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 11Health News:Tiens Biotech Group (USA) Reports Record Twelve-Month Results 12Health News:Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM) 2Health News:Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM) 3
...fectly balanced, the patented Orion incorporates s...that illuminates brilliantly. The fully adjustabl...d to sit low on the brow, directing the spot along...osition the cable diagonally over the head, balanc...
Coronary Artery Perfusion Cannulae with Balloon
...PLETH is seven pounds of intelligent Pulse Oximete... software developed over 7 years by a dedicated R&...n saturation monitoring. The combination of unique...uration sensor designs using our exclusive SuperBr...
... ODISsey Tissue Oximeter is a lightweight, portabl...ay monitor with two separate channels for up to on... adjustable alarms for low and high limits for StO...quires minimal training., ,Sensors of differen...
Medicine Products: